News Focus
News Focus
Followers 18
Posts 3354
Boards Moderated 1
Alias Born 03/16/2005

Re: None

Monday, 11/03/2025 10:11:33 AM

Monday, November 03, 2025 10:11:33 AM

Post# of 2941
Enjoy the data. Iovance will be proceeding to a BLA for nsclc TIL therapy. Hope of a CR for future patients and significant revenues will result:

https://ir.iovance.com/static-files/c13bb40a-6281-4faf-8dc3-db2b2e28770c

As shown on this release, the current standard of care can't compete with what Iovance has to offer. Unmet medical need will drive this process to completion and ultimate approval for Iovance.

GL
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IOVA News